ARCHIVES

Guest Editorial: FDA Must Address Economic Incentives to Resolve Drug Shortages Permanently

This article is from The Cancer Letter archive.

Vol. 38 No. 08 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

NCI R01 Payline Stays At 12th Percentile for FY07.

February 9, 2007

Elderly and Younger Patients Have Similar Outcomes Following Radioembolization

July 26, 2013

Guest Editorial : Why I Don’t Want to Pay for Your Horoscope: Reflections on FDA Warning to 23 and Me

December 13, 2013

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

May 16, 2008

FDA Approves Kytril For Post-Operative Nausea

October 25, 2002

SEER Expects To Lower Cancer Incidence Rates for Blacks by 3%

September 27, 2002